Public disclosure of inside information according to article 17 MAR
Leverkusen (pta023/18.06.2025/13:50) - Leverkusen, June 18, 2025
The receivables of the German Biofrontera Group from the US company Biofrontera Inc. in the amount of EUR 1.8 million, which were deferred until June 18, 2025 in accordance with the ad hoc announcement of May 27, 2025, will again be deferred until June 22, 2025. If the parties agree on a term sheet for the revision of the existing license and supply agreement between them by this date as part of the ongoing negotiations in accordance with the ad hoc announcement of 10 June 2025, the payment period will be extended again until 27 June.
The Management Board
(end)
emitter: Biofrontera AG
address: Hemmelrather Weg 201, 51377 Leverkusen
country: Germany
contact person: Investor Relations
phone: +49 (0) 214 87 63 20
e-mail: ir@biofrontera.com
website: www.biofrontera.com
ISIN(s): DE000A4BGGM7 (share)
stock exchanges: regulated market in Dusseldorf, Frankfurt; free market in Munich, free market in Stuttgart; open market in Berlin, Tradegate